PNC Financial Services Group
ABUS icon

PNC Financial Services Group’s Arbutus Biopharma ABUS Stock Holding History

PNC Financial Services Group’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.11K Sell
1,690
-179
-10% -$786 ﹤0.01% 4190
2026
Q1 		$8.41K Buy
1,869
+1,032
+123% +$4.51K ﹤0.01% 4029
2025
Q4 		$4.03K Sell
837
-713
-46% -$3.21K ﹤0.01% 4317
2025
Q3 		$7.04K Sell
1,550
-11
-0.7% -$40 ﹤0.01% 4073
2025
Q2 		$4.82K Sell
1,561
-5
-0.3% -$17 ﹤0.01% 4152
2025
Q1 		$5.46K Buy
1,566
+902
+136% +$3.01K ﹤0.01% 4030
2024
Q4 		$2.17K Sell
664
-13
-2% -$48 ﹤0.01% 4261
2024
Q3 		$2.61K Buy
677
+13
+2% +$50 ﹤0.01% 4222
2024
Q2 		$2.05K Buy
664
+456
+219% +$1.37K ﹤0.01% 4251
2024
Q1 		$537 Hold
208
– – ﹤0.01% 4486
2023
Q4 		$520 Buy
+208
New +$407 ﹤0.01% 4409
2018
Q4 		– Sell
-28,188
Closed -$266K – 4017
2018
Q3 		$266K Sell
28,188
-39,417
-58% -$391K ﹤0.01% 2038
2018
Q2 		$493K Buy
+67,605
New +$402K ﹤0.01% 1656
2015
Q3 		– Sell
-400
Closed -$5K – 4603
2015
Q2 		$5K Hold
400
– – ﹤0.01% 4058
2015
Q1 		$7K Sell
400
-500
-56% -$10.2K ﹤0.01% 3906
2014
Q4 		$14K Sell
900
-10,500
-92% -$181K ﹤0.01% 3258
2014
Q3 		$240K Buy
+11,400
New +$186K ﹤0.01% 1882

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PNC Financial Services Group's ABUS Position: Q2 2026 in Review

PNC Financial Services Group reduced its Arbutus Biopharma (ABUS) stake by 9.6% in Q2 2026, selling an estimated $786 and leaving 1,690 shares worth $8.11K. The position accounts for ﹤0.01% of the portfolio, ranked #4190.

PNC Financial Services Group first reported a position in ABUS in Q3 2014 and has held it in 17 quarters since. The position peaked at $493K in Q2 2018. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • PNC Financial Services Group held 1,690 shares of Arbutus Biopharma worth $8.11K as of Q2 2026.
  • PNC Financial Services Group sold 179 Arbutus Biopharma shares in Q2 2026, an estimated $786.
  • Arbutus Biopharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4190 holding.
  • PNC Financial Services Group first reported a position in Arbutus Biopharma in Q3 2014 and has held it in 17 quarters since.
  • PNC Financial Services Group's Arbutus Biopharma position peaked at $493K in Q2 2018.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.